EIA
ASTH icon

Emerald Investment Advisers’s Astrana Health ASTH Stock Holding History

Emerald Investment Advisers’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.34M Buy
115,045
+45,294
+65% +$1.63M 0.36% 93
2026
Q1 		$1.71M Buy
+69,751
New +$1.65M 0.15% 161

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Emerald Investment Advisers's ASTH Position: Q2 2026 in Review

Emerald Investment Advisers increased its Astrana Health (ASTH) stake by 65% in Q2 2026, buying an estimated $1.63M and bringing the position to 115,045 shares worth $5.34M. The position accounts for 0.36% of the portfolio, ranked #93.

Emerald Investment Advisers first reported a position in ASTH in Q1 2026 and has held it in 2 quarters since. 207 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Emerald Investment Advisers held 115,045 shares of Astrana Health worth $5.34M as of Q2 2026.
  • Emerald Investment Advisers bought 45,294 Astrana Health shares in Q2 2026, an estimated $1.63M.
  • Astrana Health made up 0.36% of Emerald Investment Advisers's portfolio in Q2 2026, its #93 holding.
  • Emerald Investment Advisers first reported a position in Astrana Health in Q1 2026 and has held it in 2 quarters since.
  • 207 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Emerald Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.